Molecular Partners Ag (MOLN) Cash from Operations (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Cash from Operations of 18188.38 for Q1 2026, up 4.26% year-on-year from 17445.58 in Q1 2025, and up 99.97% on a QoQ basis from 64081030.6 in Q4 2025.

Molecular Partners Ag (MOLN) Cash from Operations (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Cash from Operations for 7 consecutive years, with 18188.38 the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Operations rose 4.26% year-over-year to 18188.38 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 62854547.06 (up 4.83% YoY) and the FY2025 annual result came in at 64131210.02, up 5.18% from the prior year.
  • Cash from Operations advanced to 18188.38 in Q1 2026 per MOLN's latest filing, from 64081030.6 in the prior quarter.
  • Over the last five years, Cash from Operations for MOLN reached as high as 156597882.47 in Q2 2022 and fell as low as 156201913.72 in Q3 2022.
  • A 5-year average of 4196191.7 and a median of 18997.24 in 2025 frame the typical range for Cash from Operations.
  • The largest YoY upside for Cash from Operations was 635.85% in 2022 against a maximum downside of 373.36% in 2022.
  • Year by year, Cash from Operations stood at 122936223.52 in 2022, then plunged by 154.07% to 66471055.32 in 2023, then dropped by 1.67% to 67580315.95 in 2024, then climbed by 5.18% to 64081030.6 in 2025, then soared by 99.97% to 18188.38 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 18188.38, 64081030.6, and 37678168.26 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.59 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 201.34 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.17 Mn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -18,188.38

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,188.38
Mar 31, 2026 -18,188.38
Dec 31, 2025 -64.08 Mn
Dec 31, 2025 -64.08 Mn
Sep 30, 2025 37.68 Mn
Sep 30, 2025 37.68 Mn
Jun 30, 2025 -36.43 Mn
Jun 30, 2025 -36.43 Mn
Mar 31, 2025 -18,997.24
Mar 31, 2025 -18,997.24
Dec 31, 2024 -67.58 Mn
Dec 31, 2024 -67.58 Mn
Sep 30, 2024 37.77 Mn
Sep 30, 2024 37.77 Mn
Jun 30, 2024 -36.22 Mn
Jun 30, 2024 -36.22 Mn
Mar 31, 2024 -19,532.74
Mar 31, 2024 -19,532.74
Dec 31, 2023 -66.47 Mn
Dec 31, 2023 -66.47 Mn